Keywords: Santen Pharma, Eisai, Option agreement, Ophthalmology, Marketing company, China

Santen in ophthalmics deal with Eisai; Sets up new company in China

Article | 26 September 2012

Print This

Japan’s Santen Pharmaceutical (TYO: 4536) has entered into an option agreement with drug major Eisai (TYO: 4523) to gain rights ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in